Sherine Gabriel, M.D., M.Sc.

Conflicts of Interest:

As of February 19, 2013

Financial or Business Associations:

• Mayo Clinic (Employer)
• Genentech
• Hoffman-LaRoche
• National Institutes of Health

Personal Associations:

• FDA/CDER Drug Safety and Risk Management Advisory Committee — Member (2010–present)
• Chair, FDA/CDER Drug Safety and Risk Management Advisory Committee — Member (2011–present)
• External Advisory Board, University of Puerto Rico Post-doctoral Master of Science in Clinical Research Program, School of Medicine and School of Health Professions — Member (2006– present)
• Executive Board, Observational Medical Outcomes Partnership, Foundation for the NIH — Member (2008–present)
• Scientific Advisory Board, Excellence in Rheumatology — Member (2010–present)
• International Coordination Council, Bone and Joint Decade/Initiative — Member (2010– present)
• CTSA Academic-Industry Working Group — Chair (2010–present)
• Steering Committee, Actemra Cardiovascular Outcomes Trial (ENTRACTE), Roche — Member (2009–present)
• Pharmacoepidemiology Advisory Board, Genentech — Member (2009–present)
• External Research Education Advisory Board, University of Kentucky CTSA — Member (2011– present)
• External Research Education Advisory Committee, Georgetown University — Member (2011–present)
• Oversight Board, Welcome Trust, HRB Dublin Centre for Clinical Research — Member (2011–present)

Gabriel, a former chairperson of the Methodology Committee, served on the panel from January 2011 through September 2013.